DK3143403T3 - Fremgangsmåder til påvisning og/eller måling af anti-lægemiddelantistoffer, især behandlingsinducerede anti-lægemiddelantistoffer - Google Patents

Fremgangsmåder til påvisning og/eller måling af anti-lægemiddelantistoffer, især behandlingsinducerede anti-lægemiddelantistoffer Download PDF

Info

Publication number
DK3143403T3
DK3143403T3 DK15723216.6T DK15723216T DK3143403T3 DK 3143403 T3 DK3143403 T3 DK 3143403T3 DK 15723216 T DK15723216 T DK 15723216T DK 3143403 T3 DK3143403 T3 DK 3143403T3
Authority
DK
Denmark
Prior art keywords
drug antibodies
inducted
procedures
measurement
detection
Prior art date
Application number
DK15723216.6T
Other languages
English (en)
Inventor
Veerle Snoeck
Marie-Ange Buyse
Judith Baumeister
Original Assignee
Ablynx Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ablynx Nv filed Critical Ablynx Nv
Application granted granted Critical
Publication of DK3143403T3 publication Critical patent/DK3143403T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
DK15723216.6T 2014-05-16 2015-05-13 Fremgangsmåder til påvisning og/eller måling af anti-lægemiddelantistoffer, især behandlingsinducerede anti-lægemiddelantistoffer DK3143403T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461994472P 2014-05-16 2014-05-16
PCT/EP2015/060671 WO2015173342A1 (en) 2014-05-16 2015-05-13 Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies

Publications (1)

Publication Number Publication Date
DK3143403T3 true DK3143403T3 (da) 2022-01-17

Family

ID=53189050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15723216.6T DK3143403T3 (da) 2014-05-16 2015-05-13 Fremgangsmåder til påvisning og/eller måling af anti-lægemiddelantistoffer, især behandlingsinducerede anti-lægemiddelantistoffer

Country Status (9)

Country Link
US (2) US11009511B2 (da)
EP (2) EP3982124A1 (da)
AU (2) AU2015261467B2 (da)
CA (1) CA2948945C (da)
CY (1) CY1125342T1 (da)
DK (1) DK3143403T3 (da)
ES (1) ES2900852T3 (da)
HU (1) HUE056738T2 (da)
WO (1) WO2015173342A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3141978A1 (en) 2011-06-23 2012-12-27 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
US11009511B2 (en) * 2014-05-16 2021-05-18 Ablynx N.V. Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
WO2017220645A1 (en) * 2016-06-23 2017-12-28 Ablynx N.V. Improved pharmacokinetic assays for immunoglobulin single variable domains
WO2018178307A1 (en) 2017-03-31 2018-10-04 Ablynx N.V. Improved immunogenicity assays
CN114902052B (zh) * 2020-01-02 2025-07-18 豪夫迈·罗氏有限公司 Ada应答特异性化测定
US20260103529A1 (en) 2022-10-18 2026-04-16 Confo Therapeutics N.V. Amino Acid Sequences Directed Against the Melanocortin 4 Receptor and Polypeptides Comprising the Same for the Treatment of MC4R-Related Diseases and Disorders
AU2024273077A1 (en) 2023-05-17 2025-11-13 Odyssey Therapeutics, Inc. Modified single-domain antibodies

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100081792A1 (en) 2001-06-28 2010-04-01 Smithkline Beecham Corporation Ligand
EP1412390A2 (en) 2001-07-26 2004-04-28 Tanox, Inc. Agents that activate or inhibit toll-like receptor 9
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
FR2846667B1 (fr) 2002-11-06 2004-12-31 Pasteur Institut Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
NZ540194A (en) 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
MX2007006593A (es) 2004-12-02 2008-03-04 Domantis Ltd Anticuerpos de dominio simple anti-il 1r1 y sus usos terapeuticos.
AU2006249144B2 (en) 2005-05-18 2011-11-17 Ablynx Nv Improved NanobodiesTM against Tumor Necrosis Factor-alpha
LT2444424T (lt) 2005-05-20 2018-10-25 Ablynx N.V. Pagerintos tm nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
US7989219B2 (en) 2005-05-31 2011-08-02 Canon Kabushiki Kaisha Bispecific capturing molecule
CA2632866A1 (en) 2005-12-01 2007-06-07 Domantis Limited Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1
JP2009517069A (ja) 2005-12-01 2009-04-30 ドマンティス リミテッド インターロイキン1受容体1型に結合する競合ドメイン抗体フォーマット
FR2894741B1 (fr) 2005-12-08 2009-12-04 Centre Nat Etd Spatiales Chaine de reception par satellite
US20100047171A1 (en) 2006-01-24 2010-02-25 Roland Beckmann Fusion Proteins That Contain Natural Junctions
JP2010500876A (ja) 2006-08-18 2010-01-14 アブリンクス エン.ヴェー. Il−6媒介性シグナル伝達に関連する疾患及び障害の治療のための、il−6rに指向性を有するアミノ酸配列及びこれを含むポリペプチド
CA2706425A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
DE102008023620A1 (de) 2008-05-15 2009-11-19 Mettler-Toledo (Albstadt) Gmbh Funktionseinheit mit einer aufrufbaren Funktion und Verfahren zu deren Aufruf
US9212226B2 (en) 2008-05-16 2015-12-15 Ablynx N.V. Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
WO2010042815A2 (en) 2008-10-09 2010-04-15 Duke University Vhh antibody fragments for use in the detection and treatment of cancer
WO2010130832A2 (en) 2009-05-15 2010-11-18 Ablynx N.V. Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions
ES2804450T3 (es) 2009-07-10 2021-02-08 Ablynx Nv Método para la producción de dominios variables
US8306355B2 (en) 2009-07-13 2012-11-06 Sharp Laboratories Of America, Inc. Methods and systems for reducing compression artifacts
CA2777527C (en) * 2009-12-23 2020-06-23 Esbatech, An Alcon Biomedical Research Unit Llc Method for decreasing immunogenicity
JP2013145769A (ja) 2010-08-04 2013-07-25 Kri Inc 異方性希土類ボンド磁石とその製造方法
CA3141978A1 (en) 2011-06-23 2012-12-27 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
LT3466972T (lt) 2011-06-23 2026-06-25 Ablynx Nv Serumo albuminą surišantys baltymai
MY167125A (en) 2011-08-17 2018-08-13 Glaxo Group Ltd Modified proteins and peptides
US11009511B2 (en) * 2014-05-16 2021-05-18 Ablynx N.V. Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies

Also Published As

Publication number Publication date
EP3143403A1 (en) 2017-03-22
EP3982124A1 (en) 2022-04-13
US12553901B2 (en) 2026-02-17
AU2015261467A1 (en) 2016-12-01
CY1125342T1 (el) 2024-02-16
CA2948945A1 (en) 2015-11-19
US11009511B2 (en) 2021-05-18
AU2021201640B2 (en) 2024-08-01
AU2021201640A1 (en) 2021-04-08
EP3143403B1 (en) 2021-10-27
WO2015173342A1 (en) 2015-11-19
HUE056738T2 (hu) 2022-03-28
US20210341490A1 (en) 2021-11-04
AU2015261467B2 (en) 2020-12-17
CA2948945C (en) 2023-08-08
ES2900852T3 (es) 2022-03-18
US20170082637A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
IL257324A (en) Antibody against glypican-3 and application thereof
DK3309174T3 (da) ANTI-PD-L1-antistoffer og diagnostiske anvendelser deraf
DK3100001T3 (da) Fremgangsmåde og anordning til bestemmelse af dækslidbanedybde og/eller dæktilstand
DK3922645T3 (da) Anti-pro/latent-myostatin-antistoffer og anvendelse heraf
DK4206640T3 (da) Mikrotom
IL299926A (en) Neoantigens and methods of their use
DK3280441T3 (da) Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3303394T3 (da) Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf
DK3159406T3 (da) Kit eller indretning til påvisning af øsufagus-cancer og fremgangsmåde til påvisning
DK3258951T3 (da) Anti-pvrig antistoffer og fremgangsmåder for anvendelse
DK3116911T3 (da) Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
IL263273A (en) Anti-gitr antibodies and uses thereof
DK3156503T3 (da) Mavecancer-biomarkør og detektionsfremgangsmåde
EP3467512A4 (en) SAMPLE PROCESSING AND MEASUREMENT SYSTEM
EP3191826C0 (en) SYSTEM AND METHOD FOR MEASURING DENSITY
PL3123166T3 (pl) Wlot detektora i sposób próbkowania
DK3096684T3 (da) Anordning og fremgangsmåde til måling af kropsegenskaber
DK3152569T3 (da) Midler og fremgangsmåder til bestemmelse af t-cellegenkendelse
IL264019A (en) Method and device for signal detection
PL3554041T3 (pl) Sposób i urządzenie do określania sekwencji
GB201515487D0 (en) Methods and systems for detecting an open navigable element
DK3201624T3 (da) Indretning til detektion af hæmolyse, system og fremgangsmåde
DK3230764T3 (da) Radardetekteringssystem til skelnen mellem regnekkoer og radar til udførelse af en sådan fremgangsmåde
IL257354B1 (en) Antibodies and assays for detection of cd37